Viread Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Effects of Antiviral Therapies on Epstein-Barr Virus Replication
Condition:   Multiple Sclerosis Intervention:   Drug: Truvada (tenofovir/emtricitabine) Sponsors:   Massachusetts General Hospital;   Solving MS Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2023 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load
Conditions:   HIV Infections;   Fatty Liver Disease Interventions:   Drug: Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day;   Drug: Tenofovir disoproxil fumarate (TDF) 245 mg per day or Tenofovir alafenamide (TAF) 25 mg per day + Emtricitabine (FTC) 200 mg per day + Rilpivirine 25 mg per day;   Drug: Continue with their previous treatment. Any pre vious HAART that does not contain Rilpivirine. Sponsor:   Fundacion SEIMC-GESIDA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials